Global CRISPR And CRISPR-Associated (Cas) Genes Market Growth 2020-2025

  • receipt Report ID : 222575
  • calendar_today Published On: Feb, 2020
  • file_copy Pages: 161
  • list Pharmaceuticals and Healthcare

According to this study, over the next five years the CRISPR And CRISPR-Associated (Cas) Genes market will register a 41.5% CAGR in terms of revenue, the global market size will reach $ 2799 million by 2025, from $ 698.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in CRISPR And CRISPR-Associated (Cas) Genes business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR And CRISPR-Associated (Cas) Genes market by type, application, key manufacturers and key regions and countries.

This study considers the CRISPR And CRISPR-Associated (Cas) Genes value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Genome Editing

Genetic engineering

gRNA Database/Gene Librar

CRISPR Plasmid

Human Stem Cells

Genetically Modified Organisms/Crops

Cell Line Engineering

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Biotechnology Companies

Pharmaceutical Companies

Academic Institutes

Research and Development Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Caribou Biosciences

Intellia Therapeutics

Addgene

Merck KGaA

Mirus Bio LLC

CRISPR THERAPEUTICS

Thermo Fisher Scientific

Editas Medicine

Horizon Discovery Group

Takara Bio USA

GE Healthcare Dharmacon

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global CRISPR And CRISPR-Associated (Cas) Genes consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of CRISPR And CRISPR-Associated (Cas) Genes market by identifying its various subsegments.

Focuses on the key global CRISPR And CRISPR-Associated (Cas) Genes manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the CRISPR And CRISPR-Associated (Cas) Genes with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of CRISPR And CRISPR-Associated (Cas) Genes submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2025

2.1.2 CRISPR And CRISPR-Associated (Cas) Genes Consumption CAGR by Region

2.2 CRISPR And CRISPR-Associated (Cas) Genes Segment by Type

2.2.1 Genome Editing

2.2.2 Genetic engineering

2.2.3 gRNA Database/Gene Librar

2.2.4 CRISPR Plasmid

2.2.5 Human Stem Cells

2.2.6 Genetically Modified Organisms/Crops

2.2.7 Cell Line Engineering

2.3 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

2.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

2.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2015-2020)

2.3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)

2.4 CRISPR And CRISPR-Associated (Cas) Genes Segment by Application

2.4.1 Biotechnology Companies

2.4.2 Pharmaceutical Companies

2.4.3 Academic Institutes

2.4.4 Research and Development Institutes

2.5 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

2.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

2.5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value and Market Share by Type (2015-2020)

2.5.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)

3 Global CRISPR And CRISPR-Associated (Cas) Genes by Company

3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company

3.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Company (2018-2020)

3.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2018-2020)

3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company

3.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Company (2018-2020)

3.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2020)

3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Company

3.4 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players CRISPR And CRISPR-Associated (Cas) Genes Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 CRISPR And CRISPR-Associated (Cas) Genes by Regions

4.1 CRISPR And CRISPR-Associated (Cas) Genes by Regions

4.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

4.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

4.4 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

4.5 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

5 Americas

5.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries

5.1.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)

5.1.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)

5.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

5.3 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions

6.1.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions (2015-2020)

6.1.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Value by Regions (2015-2020)

6.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

6.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe CRISPR And CRISPR-Associated (Cas) Genes by Countries

7.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)

7.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)

7.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

7.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries

8.1.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)

8.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

8.3 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors

10.3 CRISPR And CRISPR-Associated (Cas) Genes Customer

11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Forecast

11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2021-2025)

11.2 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions

11.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions (2021-2025)

11.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Type

11.8 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Application

12 Key Players Analysis

12.1 Caribou Biosciences

12.1.1 Company Information

12.1.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Caribou Biosciences Latest Developments

12.2 Intellia Therapeutics

12.2.1 Company Information

12.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.2.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Intellia Therapeutics Latest Developments

12.3 Addgene

12.3.1 Company Information

12.3.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.3.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Addgene Latest Developments

12.4 Merck KGaA

12.4.1 Company Information

12.4.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Merck KGaA Latest Developments

12.5 Mirus Bio LLC

12.5.1 Company Information

12.5.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Mirus Bio LLC Latest Developments

12.6 CRISPR THERAPEUTICS

12.6.1 Company Information

12.6.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.6.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 CRISPR THERAPEUTICS Latest Developments

12.7 Thermo Fisher Scientific

12.7.1 Company Information

12.7.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.7.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Thermo Fisher Scientific Latest Developments

12.8 Editas Medicine

12.8.1 Company Information

12.8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.8.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Editas Medicine Latest Developments

12.9 Horizon Discovery Group

12.9.1 Company Information

12.9.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Horizon Discovery Group Latest Developments

12.10 Takara Bio USA

12.10.1 Company Information

12.10.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.10.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Takara Bio USA Latest Developments

12.11 GE Healthcare Dharmacon

12.11.1 Company Information

12.11.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 GE Healthcare Dharmacon Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. CRISPR And CRISPR-Associated (Cas) Genes Consumption CAGR by Region 2015-2025 ($ Millions)

Tabl

Please fill the form below, to recieve the report sample


+1